Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of[...]
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
11/05/2024 | Press release | Distributed by Public on 11/05/2024 05:41
Please select the service you want to use:
Smartlinks | EnPro Industries Inc. | News | Company News | Company Appointments | Board Change | Securities Issuers | Industrial Equipment and Components Manufacturers | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact